The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Will The Market Value Of The Contract Research And Manufacturing Services (CRAMS) Market Grow Between 2026 And 2030?
The contract research and manufacturing services (CRAMS) market has experienced rapid expansion in its size over recent years. It is projected to expand from $155.61 billion in 2025 to $171.86 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.4%. This historical growth is attributable to several factors, including escalating research and development (R&D) expenses within the pharmaceutical industry, an increasing need for novel medications, insufficient in-house manufacturing capacities, a rise in regulatory complexities, and the proliferation of biotechnology firms.
The contract research and manufacturing services (crams) market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $258.36 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. Factors contributing to this growth during the forecast period include the increasing uptake of biologics and advanced therapies, the broader outsourcing of clinical trials, the rising need for personalized medicine, innovations in manufacturing automation technology, and the growing trend of contract manufacturing for medical devices. Key trends expected within this period encompass the outsourcing of pharmaceutical research and development, the expansion of biologics manufacturing capabilities, heightened demand for analytical testing and quality control, an increase in custom synthesis and production services, and the growing embrace of contract manufacturing for medical devices.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6041&type=smp
What Key Drivers Are Fueling The Growth Of The Contract Research And Manufacturing Services (CRAMS) Market?
The increasing elderly demographic, often suffering from various chronic ailments, is expected to positively impact the expansion of the contract research and manufacturing services (CRAMS) market throughout the forecast period. The world’s ageing population is rapidly growing and is anticipated to continue this trend over the projected timeframe. As the geriatric population expands, the prevalence of numerous diseases such as cancer, diabetes, Alzheimer’s, arthritis, and other conditions will also rise, consequently increasing the demand for different drugs or medicines. This, in turn, will lead to a greater need for contract research and manufacturing services. For instance, in September 2023, according to the Australian Bureau of Statistics, a statistical agency based in Australia, Australia’s population, which was 26 million in 2022, is projected to grow to between 34.3 million and 45.9 million by 2071. Additionally, the median age, currently 38.5 years, is forecasted to increase to between 43.8 and 47.6 years. Therefore, the growing ageing population will drive the growth of the contract research and manufacturing services (CRAMS) market.
What Are The Different Segment Types In The Contract Research And Manufacturing Services (CRAMS) Market Segment Breakdown?
The contract research and manufacturing services (crams) market covered in this report is segmented –
1) By Services: Manufacturing, Research
2) By End User: Pharmaceutical And Biotechnology Companies, Medical Device Companies, Academic Institutes
3) By Product: API (Active Pharmaceutical Ingredient) Services, Finished Dosage Form (FDF) Services, Biologics / Cell & Gene Therapy Services, Formulation Development & Packaging
Subsegments:
1) By Manufacturing: Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Form (FDF) Manufacturing, Biologics Manufacturing, Contract Manufacturing Of Medical Devices, Formulation Development And Manufacturing, Packaging And Labeling Services, Analytical Testing And Quality Control, Custom Synthesis And Production
2) By Research: Preclinical Research, Clinical Research (Phase I-IV), Drug Discovery And Development Services, Regulatory Affairs And Consulting, Bioanalytical Testing Services, Toxicology Testing, Process Development And Optimization, Clinical Trial Management And Monitoring, Pharmacovigilance And Safety Services
What Trends Are Affecting The Direction Of The Contract Research And Manufacturing Services (CRAMS) Market?
The contract research and manufacturing services (CRAMS) market is increasingly leveraging artificial intelligence (AI) to enhance its market standing. Defined as a computer science discipline focused on mimicking human behavior in machines, AI offers benefits such as averting expensive maintenance through predictive scheduling and bolstering the healthcare infrastructure. As an illustration, Medidata, a technology firm based in the US, introduced its Clinical Data Studio in June 2024. This platform is designed to integrate and manage clinical trial data from diverse origins, thereby improving the accuracy and efficiency of clinical research. The studio employs artificial intelligence to streamline data review and reconciliation, empowering study teams to identify potential data anomalies and safety indicators more effectively. Furthermore, this platform offers an extensive workspace for the integration, transformation, and governance of data, facilitating users in implementing robust risk-based quality management approaches and gaining access to real-time intelligence.
Who Are The Well-Known Companies In The Contract Research And Manufacturing Services (CRAMS) Market?
Major companies operating in the contract research and manufacturing services (crams) market are Lonza Group, Catalent Inc., WuXi AppTec, Boehringer Ingelheim, Charles River Laboratories, Jubilant Life Sciences, PRA Health Sciences, Syngene International Ltd., Samsung Biologics, Evotec AG, AMRI (Albany Molecular Research Inc.), Parexel International Corporation, ICON plc, IQVIA Holdings Inc., PPD (Pharmaceutical Product Development), Recipharm AB, Curia Global Inc., Cambrex Corporation, Labcorp Drug Development, CordenPharma, Medpace Holdings Inc., FAMAR Health Care Services, Rentschler Biopharma SE, PCI Pharma Services, Dishman Carbogen Amcis Ltd., Thermo Fisher Scientific Inc., ProPharma Group, Siegfried AG
Get The Full Contract Research And Manufacturing Services (CRAMS) Market Report:
Which Region Is The Leading Market For The Contract Research And Manufacturing Services (CRAMS) Market?
North America was the largest region in the contract research and manufacturing services (CRAMS) market in 2025. Asia-Pacific region is expected to grow at a faster pace in the forecast period. The regions covered in the contract research and manufacturing services (crams) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Contract Research And Manufacturing Services (CRAMS) Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Contract Research And Manufacturing Services (CRAMS) Market 2026, By The Business Research Company
Contract Research And Manufacturing Services Market Report 2026
Contract Development Manufacturing Organizations Market Report 2026
Electronic Contract Manufacturing And Design Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model